Advanced search
Publication Cover
Renal Failure Volume 45, 2023 - Issue 1
Submit an article Journal homepage
1,611
Views
2
CrossRef citations to date
0
Altmetric
Clinical Study

Adverse events following the first, second and third doses of a COVID-19 vaccine in hemodialysis patients

Mei-Fen Paia Division of Nephrology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan;b Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei City, TaiwanView further author information
,
Kuei-Ting Tunga Division of Nephrology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, TaiwanView further author information
,
Shih-Ping Hsua Division of Nephrology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan;b Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei City, Taiwan;c School of Life Science, National Taiwan Normal University, Taipei City, TaiwanView further author information
,
Yu-Sen Penga Division of Nephrology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan;d Department of Applied Cosmetology, Lee-Ming Institute of Technology, New Taipei City, Taiwan;e Department of Electrical Engineering, Yuan Ze University, Taoyuan City, TaiwanView further author information
,
Wan-Yu Linf Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei City, TaiwanView further author information
,
Ju-Yeh Yanga Division of Nephrology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan;b Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei City, Taiwan;g Center for General Education, Lee-Ming Institute of Technology, New Taipei City, TaiwanView further author information
,
Hon-Yen Wua Division of Nephrology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan;b Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei City, Taiwan;h Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei City, TaiwanView further author information
,
Yen-Ling Chiua Division of Nephrology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan;b Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei City, Taiwan;i Graduate Program in Biomedical Informatics, Yuan Ze University, Taoyuan City, TaiwanView further author information
,
Kai-Hsiang Shua Division of Nephrology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan;b Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei City, TaiwanView further author information
&
Wan-Chuan Tsaia Division of Nephrology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan;g Center for General Education, Lee-Ming Institute of Technology, New Taipei City, TaiwanCorrespondence[email protected]
View further author information
 show all
Article: 2172432 | Received 07 Sep 2022, Accepted 19 Jan 2023, Published online: 30 Jan 2023

References

  • Johns Hopkins University Coronavirus Resource Center. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. 2021. Accessed on 3 September 2022 https://coronavirus.jhu.edu/map.html.
  • National Center for High-performance Computing: COVID-19 Global Dashboard by Taiwan. Accessed on 3 September 2022. https://covid-19.nchc.org.tw/dt_005-covidTable_taiwan.php.
  • Oetjens MT, Luo JZ, Chang A, et al. Electronic health record analysis identifies kidney disease as the leading risk factor for hospitalization in confirmed COVID-19 patients. PLOS One. 2020;15(11):e0242182. Published 2020 Nov 12.
  • Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436.
  • Jager KJ, Kramer A, Chesnaye NC, et al. Results from the ERA-EDTA registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe. Kidney Int. 2020;98(6):1540–1548.
  • Li P, Guan Y, Zhou S, et al. Mortality and risk factors for COVID-19 in hemodialysis patients: a systematic review and meta-analysis. Sci Prog. 2022;105(3):368504221110858. 368504221110858.
  • Chen JJ, Lee TH, Tian YC, et al. Immunogenicity rates after SARS-CoV-2 vaccination in people with end-stage kidney disease: a systematic review and meta-analysis. JAMA Netw Open. 2021;4(10):e2131749. Published 2021 Oct 1.
  • Sanders JF, Bemelman FJ, Messchendorp AL, et al. The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant. Transplantation. 2022;106(4):821–834.
  • Frittoli M, Cassia M, Barassi A, et al. Efficacy and safety of COVID-19 vaccine in patients on renal replacement therapy. Vaccines. 2022;10(9):1395. Published 2022 Aug 25.
  • Tung KT, Peng YS, Hsu SP, et al. Humoral antibody response to the first dose of the ChAdOx1 nCoV-19 vaccine in Asian patients undergoing hemodialysis [published online ahead of print, 2022 Apr 11]. Hemodial Int. 2022;26(3):369–376.
  • Garcia P, Montez-Rath ME, Moore H, et al. SARS-CoV-2 vaccine acceptability in patients on hemodialysis: a nationwide survey [published online ahead of print, 2021 Apr 29]. JASN. 2021;32(7):1575–1581. ASN.2021010104.
  • Menni C, Klaser K, May A, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID symptom study app in the UK: a prospective observational study. Lancet Infect Dis. 2021;21(7):939–949.
  • Beatty AL, Peyser ND, Butcher XE, et al. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Netw Open. 2021;4(12):e2140364. Published 2021 Dec 1. 40364
  • Meo SA, Bukhari IA, Akram J, et al. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and moderna vaccines. Eur Rev Med Pharmacol Sci. 2021;25(3):1663–1669.
  • Parshina E, Zulkarnaev A, Tolkach A, et al. Patients receiving hemodialysis do not lose SARS-CoV-2 antibodies more rapidly than non-renal controls: a prospective cohort study. Ren Fail. 2022;44(1):392–398.
  • Barrett JR, Belij-Rammerstorfer S, Dold C, et al. Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses [published correction appears in Nat Med. 2021 Jun;27(6):1113]. Nat Med. 2021;27(2):279–288.
  • Ramasamy MN, Minassian AM, Ewer KJ, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial [published correction appears in lancet. 2021 Dec 19;396(10267):1978] [published correction appears in Lancet. 2021 Apr 10;397(10282):1350]. Lancet. 2020;396(10267):1979–1993.
  • Falsey AR, Sobieszczyk ME, Hirsch I, et al. Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) covid-19 vaccine. N Engl J Med. 2021;385(25):2348–2360.
  • Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615.
  • Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–416.
  • Kitagawa H, Kaiki Y, Sugiyama A, et al. Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan. J Infect Chemother. 2022;28(4):576–581.
  • Green MS, Peer V, Magid A, et al. Gender differences in adverse events following the Pfizer-BioNTech COVID-19 vaccine. Vaccines. 2022;10(2):233. Published 2022 Feb 3.
  • Alfano G, Morisi N, Fontana F, et al. Reactogenicity of COVID-19 vaccine in hemodialysis patients: a single-center retrospective study. G Ital Nefrol. 2022;39(2) 2022-vol2. Published 2022 Apr 21.
  • Lok CE, Huber TS, Lee T, et al. KDOQI clinical practice guideline for vascular access: 2019 update [published correction appears in am J kidney dis. 2021 Apr;77(4):551]. Am J Kidney Dis. 2020;75(4 Suppl 2):S1–S164.
  • Silva A, Hobson MB, Jr, Pappas RW, et al. A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. J Vasc Surg. 1998;27(2):302–308.
  • Sherwood ER, Toliver-Kinsky T. Mechanisms of the inflammatory response. Best Pract Res Clin Anaesthesiol. 2004;18(3):385–405.
  • Lee T, Thamer M, Zhang Q, et al. Vascular access type and clinical outcomes among elderly patients on hemodialysis. Clin J Am Soc Nephrol. 2017;12(11):1823–1830.
  • Marzouq MK, Samoudi AF, Samara A, et al. Exploring factors associated with pain in hemodialysis patients: a multicenter cross-sectional study from Palestine. BMC Nephrol. 2021;22(1):96. Published 2021 Mar 17.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.